AIMC Journal:
Blood neoplasia

Machine learning and deep learning tools have been proposed to improve survival prediction in acute myeloid leukemia (AML), but comparative benchmarks remain unclear. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 se...

Immune checkpoint blockade, particularly programmed cell death protein 1 inhibition, has redefined the management of classic Hodgkin lymphoma (cHL), achieving unprecedented efficacy in relapsed/refractory settings. Yet, durable benefit is not univers...